1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. ViroGates A/S
  6. News
  7. Sector news
    VIRO   DK0061030574

VIROGATES A/S

(VIRO)
Delayed Nasdaq Copenhagen  -  05/25 10:17:27 am EDT
77.80 DKK   +3.18%
09:44aViroGates announces the CE-IVD accreditation of its finger-prick blood-testing product, suPARnostic® POC+
AQ
05/10VIROGATES : Healthy growth
AQ
05/04VIROGATES ANNOUNCES ITS INTERIM REPORT FOR Q1, 2022 : Record quarterly revenue and doubling of clinical customers
AQ
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Diagnostics & Testing
05/24Goldman Sachs Adjusts Price Target for Iovance Biotherapeutics to $64 From $79, Keeps B..
MT
05/21Guardant Health, Inc. Presents New Data Showing Blood Test Accuracy in Detecting Colore..
CI
05/19BGI Genomics Co., Ltd. Approves Cash Dividend for the Year 2021
CI
05/12Exclusive-Biden eyes new ways to bar China from scooping up U.S. data
RE
05/11TRANSCRIPT : Exact Sciences Corporation Presents at Bank of America 2022 Healthcare Confer..
CI
05/10TRANSCRIPT : Guardant Health, Inc. Presents at Bank of America 2022 Healthcare Conference,..
CI
05/09JPMorgan Adjusts Price Target for Guardant Health to $125 From $150, Maintains Overweig..
MT
05/09Morgan Stanley Lowers Guardant Health's Price Target to $85 From $120, Maintains Overwe..
MT
05/09BGI Genomics Develops Hepatitis Test Kits For Children
MT
05/06Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case
RE
05/06Guardant Health Shares Drop Following Wider Q1 Non-GAAP Loss But Higher Revenue
MT
05/06Guardant Health, Inc. Announces Resignation of Dr. Bahija Jallal as a Director
CI
05/05Earnings Flash (GH) GUARDANT HEALTH Reports Q1 Loss $-0.91, vs. Street Est of $-1.10
MT
05/05Earnings Flash (GH) GUARDANT HEALTH Reports Q1 Revenue $96.1M, vs. Street Est of $95.7M
MT
05/05TRANSCRIPT : Guardant Health, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/05TRANSCRIPT : Iovance Biotherapeutics, Inc., Q1 2022 Earnings Call, May 05, 2022
CI
05/05Iovance Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended Marc..
CI
05/05Guardant Health, Inc. Provides Revenue Guidance for the Year 2022
CI
05/05Guardant Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 20..
CI
05/02Guardant Health, Inc. Announces Shield™ Blood Test Available in US to Detect Early..
CI
05/02Exact Sciences Corporation completed the acquisition of Omicera Diagnostics Gmbh.
CI
04/29Exact Sciences Corporation Receives a Shareholder Proposal from James McRitchie
CI
04/29American Society of Clinical Oncology Guidelines Strong Recommendation of Use of the On..
CI
04/27SECTOR UPDATE : Health Care Stocks Posting Small Gains Ahead of Wednesday's Close
MT
04/27SECTOR UPDATE : Health Care Stocks Carried Higher in Wednesday Trade
MT
04/27BofA Securities Adjusts Exact Sciences' Price Target to $95 from $105, Keeps Buy Rating
MT
04/27Citigroup Adjusts Price Target on Exact Sciences to $65 From $80, Maintains Neutral Rat..
MT
04/27Goldman Sachs Adjusts Price Target for Exact Sciences to $75 From $85, Maintains Buy Ra..
MT
04/27Baird Adjusts Price Target on Exact Sciences to $90 From $100, Keeps Outperform Rating
MT
04/27Raymond James Adjusts Price Target on Exact Sciences to $80 From $90, Keeps Outperform ..
MT
04/27SVB Leerink Adjusts Price Target on Exact Sciences to $95 From $130, Keeps Outperform R..
MT
04/26Exact Sciences Corporation Reports Earnings Results for the First Quarter Ended March 3..
CI
04/26TRANSCRIPT : Exact Sciences Corporation, Q1 2022 Earnings Call, Apr 26, 2022
CI
04/26Exact Sciences Q1 Loss Per Share Widens, But Narrower Than Expectations; Revises 2022 G..
MT
04/26Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Posts Q1 Revenue $486.6M, vs. Street E..
MT
04/26Earnings Flash (EXAS) EXACT SCIENCES CORPORATION Posts Q1 Loss $-1.04, vs. Street Est o..
MT
04/26Exact Sciences Corporation Raises Revenue Guidance for the Year 2022
CI
04/26TRANSCRIPT : Iovance Biotherapeutics, Inc. Presents at Chardan’s 6th Annual Genetic M..
CI
04/26Seegene, Inc. Unveils World's First Commercialized '3 Ct' PCR Assay
CI
04/25BGI Genomics Co., Ltd. Announces Final Cash Dividend Proposal for 2021
CI
04/22BGI Genomics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2..
CI
04/11Guardant Health, Inc. Presents New Data Showing Blood Test Highly Accurate in Detecting..
CI
04/07Baird Adjusts Iovance Biotherapeutics' Price Target to $34 from $30, Keeps Outperform R..
MT
04/06TRANSCRIPT : Iovance Biotherapeutics, Inc. - Special Call
CI
04/06Seegene's Allplex™ RV Master Assay Receives Australian TGA Approval
CI
04/05Iovance Biotherapeutics Set to Submit Biologics License Application for Lifileucel in M..
MT
04/05Iovance Biotherapeutics, Inc. Announces Regulatory and Clinical Updates for Lifileucel ..
CI
04/04Guardant Health Teams Up With Epic for Easier Access to Cancer Tests
MT
04/04Guardant Health Inc. Announces Partnership with Epic to Streamline Access to Broad Port..
CI
03/17TRANSCRIPT : Iovance Biotherapeutics, Inc. Presents at Barclays Global Healthcare Conferen..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on VIROGATES A/S